| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 524669 | Hester Bios Hester Biosciences Ltd | 05-Nov-2026 | Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026 |
| 524628 | Parker Agrochem Parker Agrochem Exports Ltd | 05-Nov-2026 | Parker Agrochem Exports Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve Board Meeting for taking on record Unaudited Financial Results for the quarter ended on 30th September 2026 |
| 526435 | Perfectpac Perfectpac Ltd | 05-Nov-2026 | Perfectpac Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter and Half Year ended September 30 2026. |
| 526492 | Rishiroop Rishiroop Ltd | 05-Nov-2026 | Quarterly Results |
| 526616 | Natl. Plastic National Plastic Industries Ltd | 05-Nov-2026 | National Plastic Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve As per the enclosed letter. |
| 526751 | Gratex Industrie Gratex Industries Ltd | 05-Nov-2026 | Gratex Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026. |
| 526841 | Shakti Press Shakti Press Ltd | 05-Nov-2026 | Shakti Press Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve and take on record the Unaudited Financial Results of the Company for the second quarter and half-year ended September 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. 2. To take up reconsider and evaluate the proposal for fund raising by way of issue of securities / equity shares / convertible instruments through Qualified Institutional Placement (QIP) private placement / preferential issue rights issue or through any other permissible mode and/or combination thereof which could not be concluded in the previous Board Meeting held on Monday October 26 2026 and was deferred for further deliberations subject to statutory and shareholder approvals. 3. Any other business matter with the permission of the Chair. |
| 530001 | Gujarat Alkalies Gujarat Alkalies & Chemicals Ltd | 05-Nov-2026 | Gujarat Alkalies And Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve In compliance of Regulation 29 (1) (a) of SEBI (LODR) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company will be held on Thursday, the 5th November, 2026 for inter alia considering Standalone & Consolidated Un-Audited (Provisional) Financial Results for the Second Quarter and Half year ended on 30th September, 2026. For more details kindly refer attached file. |
| 530199 | Themis Medicare Themis Medicare Ltd | 05-Nov-2026 | Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026 |
| 530185 | Surat Trade Surat Trade & Merchantile Ltd | 05-Nov-2026 | Surat Trade And Mercantile Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year Ended 30th September 2026. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
